Induced pluripotent stem cells (iPSCs) can differentiate into mineralizing cells and are, therefore, expected to be useful for bone regenerative medicine; however, the characteristics of iPSC-derived osteogenic cells remain unclear. Here, we provide a direct in vitro comparison of the osteogenic differentiation process in mesenchymal stem cells (MSCs) and iPSCs from adult C57BL/6J mice. After 30 days of culture in osteogenic medium, both MSCs and iPSCs produced robustly mineralized bone nodules that contained abundant calcium phosphate with hydroxyapatite crystal formation. Mineral deposition was significantly higher in iPSC cultures than in MSC cultures. Scanning electron microscopy revealed budding matrix vesicles in early osteogenic iPSCs; subsequently, the vesicles propagated to exhibit robust mineralization without rich fibrous structures. Early osteogenic MSCs showed deposition of many matrix vesicles in abundant collagen fibrils that became solid mineralized structures. Both cell types demonstrated increased expression of osteogenic marker genes, such as runx2, osterix, dlx5, bone sialoprotein (BSP), and osteocalcin, during osteogenesis; however, real-time reverse transcription–polymerase chain reaction array analysis revealed that osteogenesis-related genes encoding mineralization-associated molecules, bone morphogenetic proteins, and extracellular matrix collagens were differentially expressed between iPSCs and MSCs. These data suggest that iPSCs are capable of differentiation into mature osteoblasts whose associated hydroxyapatite has a crystal structure similar to that of MSC-associated hydroxyapatite; however, the transcriptional differences between iPSCs and MSCs could result in differences in the mineral and matrix environments of the bone nodules. Determining the biological mechanisms underlying cell-specific differences in mineralization during in vitro iPSC osteogenesis may facilitate the development of clinically effective engineered bone.
Get full access to this article
View all access options for this article.
References
1.
GreenwaldAS, BodenSD, GoldbergVM, KhanY, LaurencinCT and RosierRN. (2001). Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am, 83-ASuppl 2 Pt 2:98–103.
2.
De LongWGJr., EinhornTA, KovalK, McKeeM, SmithW, SandersR and WatsonT. (2007). Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am, 89:649–658.
3.
EgusaH. (2012). iPS cells in dentistry. Clin Calcium, 22:67–73.
4.
EgusaH, SonoyamaW, NishimuraM, AtsutaI and AkiyamaK. (2012). Stem cells in dentistry—Part II: clinical applications. J Prosthodont Res, 56:229–248.
5.
MeijerGJ, de BruijnJD, KooleR and van BlitterswijkCA. (2007). Cell-based bone tissue engineering. PLoS Med, 4:e9
6.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
7.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
8.
EgusaH, SonoyamaW, NishimuraM, AtsutaI and AkiyamaK. (2012). Stem cells in dentistry—part I: stem cell sources. J Prosthodont Res, 56:151–165.
9.
VaterC, KastenP and StiehlerM. (2011). Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater, 7:463–477.
10.
TashiroK, InamuraM, KawabataK, SakuraiF, YamanishiK, HayakawaT and MizuguchiH. (2009). Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells, 27:1802–1811.
11.
LiF, BronsonS and NiyibiziC. (2010). Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem, 109:643–652.
12.
LiF and NiyibiziC. (2012). Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo. BMC Cell Biol, 13:35
13.
OkamotoH, MatsumiY, HoshikawaY, TakuboK, RyokeK and ShiotaG. (2012). Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells. PLoS One, 7:e43800
14.
KaoCL, TaiLK, ChiouSH, ChenYJ, LeeKH, ChouSJ, ChangYL, ChangCM, ChenSJ, KuHH and LiHY. (2010). Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev, 19:247–258.
15.
BilousovaG, Jun duH, KingKB, De LangheS, ChickWS, TorchiaEC, ChowKS, KlemmDJ, RoopDR and MajkaSM. (2011). Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells, 29:206–216.
16.
HayashiT, MisawaH, NakaharaH, NoguchiH, YoshidaA, KobayashiN, TanakaM and OzakiT. (2012). Transplantation of osteogenically differentiated mouse iPS cells for bone repair. Cell Transplant, 21:591–600.
17.
BonewaldLF, HarrisSE, RosserJ, DallasMR, DallasSL, CamachoNP, BoyanB and BoskeyA. (2003). von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int, 72:537–547.
18.
EgusaH, OkitaK, KayashimaH, YuG, FukuyasuS, SaekiM, MatsumotoT, YamanakaS and YataniH. (2010). Gingival fibroblasts as a promising source of induced pluripotent stem cells. PLoS One, 5:e12743
19.
EgusaH, KobayashiM, MatsumotoT, SasakiJ, UraguchiS and YataniH. (2013). Application of cyclic strain for accelerated skeletal myogenic differentiation of mouse bone marrow-derived mesenchymal stromal cells with cell alignment. Tissue Eng Part A, 19:770–782.
20.
SasakiJ, MatsumotoT, EgusaH, MatsusakiM, NishiguchiA, NakanoT, AkashiM, ImazatoS and YataniH. (2012). In vitro reproduction of endochondral ossification using a 3D mesenchymal stem cell construct. Integr Biol, 4:1207–1214.
21.
EgusaH, SchweizerFE, WangCC, MatsukaY and NishimuraI. (2005). Neuronal differentiation of bone marrow-derived stromal stem cells involves suppression of discordant phenotypes through gene silencing. J Biol Chem, 280:23691–23697.
22.
Itskovitz-EldorJ, SchuldinerM, KarsentiD, EdenA, YanukaO, AmitM, SoreqH and BenvenistyN. (2000). Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med, 6:88–95.
23.
KawaguchiJ, MeePJ and SmithAG. (2005). Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone, 36:758–769.
24.
EgusaH, KanedaY, AkashiY, HamadaY, MatsumotoT, SaekiM, ThakorDK, TabataY, MatsuuraN and YataniH. (2009). Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts. Biomaterials, 30:4676–4686.
25.
MatsumotoM, MiuraJ, TakeshigeF and YataniH. (2013). Mechanical and morphological evaluation of the bond-dentin interface in direct resin core build-up method. Dental Mater, 29:287–293.
26.
ShivaliG, PrafulL and VijayG. (2012). A validated Fourier transform infrared spectroscopy method for quantification of total lactones in Inula racemosa and Andrographis paniculata. Phytochem Anal, 23:171–176.
27.
SatoT. (1968). A modified method for lead staining of thin sections. J Eelectron Microsc, 17:158–159.
28.
KimYK, GuLS, BryanTE, KimJR, ChenL, LiuY, YoonJC, BreschiL, PashleyDH and TayFR. (2010). Mineralisation of reconstituted collagen using polyvinylphosphonic acid/polyacrylic acid templating matrix protein analogues in the presence of calcium, phosphate and hydroxyl ions. Biomaterials, 31:6618–6627.
29.
LiuY, KimYK, DaiL, LiN, KhanSO, PashleyDH and TayFR. (2011). Hierarchical and non-hierarchical mineralisation of collagen. Biomaterials, 32:1291–1300.
30.
SchmittgenTD and LivakKJ. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3:1101–1108.
31.
ButteryLD, BourneS, XynosJD, WoodH, HughesFJ, HughesSP, EpiskopouV and PolakJM. (2001). Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng, 7:89–99.
32.
SchoetersGE, de Saint-GeorgesL, Van den HeuvelR and VanderborghtO. (1988). Mineralization of adult mouse bone marrow in vitro. Cell Tissue Kinet, 21:363–374.
33.
BoskeyA and Pleshko CamachoN. (2007). FT-IR imaging of native and tissue-engineered bone and cartilage. Biomaterials, 28:2465–2478.
34.
KawaguchiJ. (2006). Generation of osteoblasts and chondrocytes from embryonic stem cells. Methods Mol Biol, 330:135–148.
35.
McCullochCA, StrugurescuM, HughesF, MelcherAH and AubinJE. (1991). Osteogenic progenitor cells in rat bone marrow stromal populations exhibit self-renewal in culture. Blood, 77:1906–1911.
36.
JaiswalN, HaynesworthSE, CaplanAI and BruderSP. (1997). Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem, 64:295–312.
37.
PurpuraKA, AubinJE and ZandstraPW. (2004). Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells, 22:39–50.
38.
AubinJE. (1999). Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. J Cell Biochem, 72:396–410.
39.
BrownSE, TongW and KrebsbachPH. (2009). The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs, 189:256–260.
40.
ArpornmaeklongP, BrownSE, WangZ and KrebsbachPH. (2009). Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev, 18:955–968.
41.
GentlemanE, SwainRJ, EvansND, BoonrungsimanS, JellG, BallMD, SheanTA, OyenML, PorterA and StevensMM. (2009). Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater, 8:763–770.
42.
KomoriT. (2010). Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol, 658:43–49.
43.
MatsubaraT, KidaK, YamaguchiA, HataK, IchidaF, MeguroH, AburataniH, NishimuraR and YonedaT. (2008). BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem, 283:29119–29125.
44.
RyooHM, LeeMH and KimYJ. (2006). Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene, 366:51–57.
45.
LiuG, VijayakumarS, GrumolatoL, ArroyaveR, QiaoH, AkiriG and AaronsonSA. (2009). Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol, 185:67–75.
46.
EirakuM, TakataN, IshibashiH, KawadaM, SakakuraE, OkudaS, SekiguchiK, AdachiT and SasaiY. (2011). Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature, 472:51–56.
47.
SugaH, KadoshimaT, MinaguchiM, OhgushiM, SoenM, NakanoT, TakataN, WatayaT, MugurumaK, et al. (2011). Self-formation of functional adenohypophysis in three-dimensional culture. Nature, 480:57–62.
48.
GothardD, RobertsSJ, ShakesheffKM and ButteryLD. (2010). Engineering embryonic stem-cell aggregation allows an enhanced osteogenic differentiation in vitro. Tissue Eng Part C Methods, 16:583–595.
49.
ShimkoDA, BurksCA, DeeKC and NaumanEA. (2004). Comparison of in vitro mineralization by murine embryonic and adult stem cells cultured in an osteogenic medium. Tissue Eng, 10:1386–1398.
50.
BigdeliN, de PeppoGM, LennerasM, SjovallP, LindahlA, HyllnerJ and KarlssonC. (2010). Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells. Tissue Eng Part A, 16:3427–3440.
51.
BoonrungsimanS, GentlemanE, CarzanigaR, EvansND, McCombDW, PorterAE and StevensMM. (2012). The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc Natl Acad Sci U S A, 109:14170–14175.
Jahnen-DechentW, SchaferC, KettelerM and McKeeMD. (2008). Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med, 86:379–389.
54.
AtkinsGJ, RowePS, LimHP, WelldonKJ, OrmsbyR, WijenayakaAR, ZelenchukL, EvdokiouA and FindlayDM. (2011). Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res, 26:1425–1436.
55.
SchaferC, HeissA, SchwarzA, WestenfeldR, KettelerM, FloegeJ, Muller-EsterlW, SchinkeT and Jahnen-DechentW. (2003). The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest, 112:357–366.
56.
CoenG, BallantiP, SilvestriniG, MantellaD, ManniM, Di GiulioS, PisanoS, LeopizziM, Di LulloG and BonucciE. (2009). Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients. Virchows Arch, 454:263–271.
57.
van BezooijenRL, RoelenBA, VisserA, van der Wee-PalsL, de WiltE, KarperienM, HamersmaH, PapapoulosSE, ten DijkeP and LowikCW. (2004). Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med, 199:805–814.
58.
SchinkeT, AmendtC, TrindlA, PoschkeO, Muller-EsterlW and Jahnen-DechentW. (1996). The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem, 271:20789–20796.
59.
KrebsbachPH, LeeSK, MatsukiY, KozakCA, YamadaKM and YamadaY. (1996). Full-length sequence, localization, and chromosomal mapping of ameloblastin. A novel tooth-specific gene. J Biol Chem, 271:4431–4435.
60.
DeutschD, PalmonA, FisherLW, KolodnyN, TermineJD and Young.MF (1991). Sequencing of bovine enamelin (“tuftelin”.) a novel acidic enamel protein. J Biol Chem, 266:16021–16028.
61.
MaoZ, ShayB, HekmatiM, FermonE, TaylorA, DafniL, HeikinheimoK, LustmannJ, FisherLW, YoungMF and DeutschD. (2001). The human tuftelin gene: cloning and characterization. Gene, 279:181–196.
62.
HatakeyamaJ, FukumotoS, NakamuraT, HaruyamaN, SuzukiS, HatakeyamaY, ShumL, GibsonCW, YamadaY and KulkarniAB. (2009). Synergistic roles of amelogenin and ameloblastin. J Dent Res, 88:318–322.
63.
IizukaS, KudoY, YoshidaM, TsunematsuT, YoshikoY, UchidaT, OgawaI, MiyauchiM and TakataT. (2011). Ameloblastin regulates osteogenic differentiation by inhibiting Src kinase via cross talk between integrin beta1 and CD63. Mol Cell Biol, 31:783–792.
64.
SpahrA, LyngstadaasSP, SlabyI and PezeshkiG. (2006). Ameloblastin expression during craniofacial bone formation in rats. Eur J Oral Sci, 114:504–511.
65.
YamaguchiA, KomoriT and SudaT. (2000). Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev, 21:393–411.
66.
ChengH, JiangW, PhillipsFM, HaydonRC, PengY, ZhouL, LuuHH, AnN, BreyerB, et al. (2003). Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am, 85-A:1544–1552.
67.
Ayala-PenaVB, ScolaroLA and SantillanGE. (2013). ATP and UTP stimulate bone morphogenetic protein-2,-4 and -5 gene expression and mineralization by rat primary osteoblasts involving PI3K/AKT pathway. Exp Cell Res, 319:2028–2036.
68.
WutzlA, BrozekW, LernbassI, RaunerM, HofbauerG, SchopperC, WatzingerF, PeterlikM and PietschmannP. (2006). Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A, 77:75–83.
69.
KarnerE, UngerC, SloanAJ, Ahrlund-RichterL, SugarsRV and WendelM. (2007). Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev, 16:39–52.
70.
KokabuS, GamerL, CoxK, LoweryJ, TsujiK, RazR, EconomidesA, KatagiriT and RosenV. (2012). BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol Endocrinol, 26:87–94.
BrinckmannJ. (2005). Collagens at a glance. In: Collagen. BrinckmannJ, NotbohmH, MüllerPK, eds. Springer, Berlin, pp 1–6.
73.
EgusaH, IidaK, KobayashiM, LinTY, ZhuM, ZukPA, WangCJ, ThakorDK, HedrickMH and NishimuraI. (2007). Downregulation of extracellular matrix-related gene clusters during osteogenic differentiation of human bone marrow- and adipose tissue-derived stromal cells. Tissue Eng, 13:2589–2600.
74.
SasakiJ, AsohTA, MatsumotoT, EgusaH, SohmuraT, AlsbergE, AkashiM and YataniH. (2010). Fabrication of three-dimensional cell constructs using temperature-responsive hydrogel. Tissue Eng Part A, 16:2497–2504.
75.
MaheraliN, SridharanR, XieW, UtikalJ, EminliS, ArnoldK, StadtfeldM, YachechkoR, TchieuJ, et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 1:55–70.
76.
AngueraMC, SadreyevR, ZhangZ, SzantoA, PayerB, SheridanSD, KwokS, HaggartySJ, SurM, et al. (2012). Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell, 11:75–90.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
